sleep apnea and glp-1 Frontiers GLP-1 drugs might help quell

As the GLP-1 economy cools, CVS Ventures leads a $25 million round in Knownwell betting on physician-led obesity care and payer-backed innovation.

doi: 10.1093/jn/nxac026 Yamada T, Shintani T, Iida T, Kishimoto Y, Okuma K

For now, the tension between innovation and compliance remains a defining feature of the GLP-1 landscape

GLP-1 medications such as Ozempic and Wegovy have quickly become some of the most talked about tools in the arsenal of weight loss and type 2 diabetes management. While knowledge of GLP-1 medications is growing, there remains some questions surrounding how they work, how fast they work, who should take them, and wheth